by Scott Scheirey In between work, bombing ski runs and taking my dog out to play, I had the opportunity to read Jesse Johnson’s recently released Leading Biotech Data Teams. His message really hit home for me, and if you’re interested in early-stage biotech research,...
By Scott Scheirey AWS re:Invent 2022 had over 50,000 attendees eagerly awaiting the latest releases that will ultimately push cloud innovation in years to come. Amazon releases thousands of ‘significant services and features’ every year, which ultimately transform the...
Aaron Jeskey, Sr. Cloud Architect of PTP sits with Jon Myer of Myer Media to deconstruct High Performance Computing, HPC, and how it can accelerate pipeline workflows in AWS. Great conversation between Jon and Aaron getting under the hood of HPC what PTP is doing for...
Overview Adaptive Phage Therapeutics (APT) is a clinical-stage biotech advancing therapies to treat multi-drug resistant infections. Prior approaches in antimicrobials have been ‘fixed’ while the pathogens continue to evolve resistance – therefore all have either...
Due to the high volume of R&D involved in software design and development processes in Life Sciences and Biotechnology, companies in this sector are ideal candidates to claim R&D Tax Credits. A portion of investment in activities, like developing and testing...
Originally broadcast on March 1, 2022, this Life Sciences focused webinar was aimed at helping data scientists and IT organizations with bioinformatics data management. We talked lab functions, lab applications, moving data from on-prem to the cloud for data...
